| T cells specific for α-myosin drive immunotherapy-related myocarditis ML Axelrod, WC Meijers, EM Screever, J Qin, MG Carroll, X Sun, ... Nature 611 (7937), 818-826, 2022 | 194 | 2022 |
| Tumor-specific major histocompatibility-II expression predicts benefit to anti–PD-1/L1 therapy in patients with HER2-negative primary breast cancer PI Gonzalez-Ericsson, JD Wulfkhule, RI Gallagher, X Sun, ML Axelrod, ... Clinical Cancer Research 27 (19), 5299-5306, 2021 | 63 | 2021 |
| NKG2A is a therapeutic vulnerability in immunotherapy resistant MHC-I heterogeneous triple-negative breast cancer BC Taylor, X Sun, PI Gonzalez-Ericsson, V Sanchez, ME Sanders, ... Cancer discovery 14 (2), 290-307, 2024 | 16 | 2024 |
| Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma SK Wong, SM Blum, X Sun, IP Da Silva, L Zubiri, F Ye, K Bai, K Zhang, ... European Journal of Cancer 181, 188-197, 2023 | 11 | 2023 |
| Mediator subunit MED1 modulates intranuclear dynamics of the thyroid hormone receptor MR Femia, RM Evans, J Zhang, X Sun, CJ Lebegue, VR Roggero, ... Journal of cellular biochemistry 121 (4), 2909-2926, 2020 | 11 | 2020 |
| Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance JL James, BC Taylor, ML Axelrod, X Sun, LN Guerin, ... Journal for Immunotherapy of Cancer 11 (11), e007736, 2023 | 5 | 2023 |
| Peripheral blood monocyte abundance predicts outcomes in patients with breast cancer ML Axelrod, Y Wang, Y Xu, X Sun, CA Bejan, PI Gonzalez-Ericsson, ... Cancer research communications 2 (5), 286-292, 2022 | 5 | 2022 |
| Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer EC Wescott, X Sun, P Gonzalez-Ericsson, A Hanna, BC Taylor, ... Cancer research communications 4 (4), 1120-1134, 2024 | 2 | 2024 |
| 812 Erythema nodosum-like toxicity in an immunotherapy treated patient is accompanied by oligoclonal memory activated CD4 T cells X Sun, M Axelrod, Y Wang, V Sanchez, P Gonzalez-Ericsson, D Johnson, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A848-A848, 2021 | 1 | 2021 |
| Thyroid Hormone Receptor and Coregulators: A Dynamic Model X Sun | 1 | 2019 |
| Peripheral blood biomarkers in monitoring treatment response in breast cancer patients AA Ocampo, X Sun, JM Balko Expert Review of Molecular Diagnostics, 2025 | | 2025 |
| In situ detection of individual classical MHC-I gene products in cancer PI Gonzalez-Ericsson, SR Opalenik, V Sanchez, A Palubinsky, A Hanna, ... Cancer Immunology Research, 2025 | | 2025 |
| Associations of Immune Checkpoint Predictive Biomarkers (MHC-I and MHC-II) with Clinical and Molecular Features in a Diverse Breast Cancer Cohort X Sun, LC Kennedy, PI Gonzalez-Ericsson, V Sanchez, M Sanders, ... Clinical Cancer Research 30 (18), 4077-4081, 2024 | | 2024 |
| Nuclear Receptor Corepressor 1 Regulates Thyroid Hormone Receptor Nuclear Retention X Sun, L Allison The FASEB Journal 33 (S1), 476.27-476.27, 2019 | | 2019 |